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tsZ is an essential protein of the bacterial cell division machinery. During cell division, it assembles into a contractile ring called the "Z-ring" at the midcell position.
1,2
Recent studies have recognized FtsZ as a promising antimicrobial drug target. 3−8 Several inhibitors of FtsZ that inhibit the proliferation of Gram-positive and Gram-negative bacteria by affecting FtsZ assembly dynamics have been identified. 7−18 Because FtsZ is strongly homologous to tubulin in structure but weakly similar to tubulin in sequence, small molecule inhibitors of FtsZ may also show activities against mammalian cells. However, inhibitors targeting FtsZ assembly in bacteria and not possessing much cytotoxicity toward mammalian cells as compared to bacterial cells should be qualified as suitable FtsZ-targeted agents. 19, 20 In this regard, noncytotoxic taxanes can serve as potential molecules for the development of FtsZ inhibitors. 21 Different members of taxanes show different cytotoxic effects toward the proliferation of mammalian cells. For example, paclitaxel ( Figure 1A) , bearing an N-benzoylphenylisoserine moiety at C13, shows a very high level of cytotoxicity in mammalian cells, whereas taxane reversal agents (TRAs), bearing a hydrophobic 3-arylacrylic acid moiety at C13 or C7, are found to be noncytotoxic. 21 A library of 120 taxanes was designed, and their antibacterial properties against Mycobacterium tuberculosis (Mtb) cells were assessed. 6, 22 The SB-RA series of TRAs having an (E)-3-(naphtha-2-yl)acryloyl (2-NpCHCHCO) group at C13 demonstrated a MIC 99 between 2.5 and 5 μM against drug-sensitive and drug-resistant Mtb strains. 6, 22 On the basis of the MIC 99 values and cytotoxicity assay, SB-RA-2001 ( Figure 1A ) was selected as a potential compound for antitubercular drug discovery. Further, the cytotoxic effect of SB-RA-2001 in human cancer cell lines was found to be significantly reduced (by 3 orders of magnitude) compared to that of paclitaxel. 22 Therefore, SB-RA-2001 could be used as a promising compound for the development of noncytotoxic taxane-based FtsZ-targeted antibacterial agents. 22 This study evaluates the effects of SB-RA-2001 on FtsZ assembly and elucidates its antibacterial mechanism. SB-RA-2001 treatment induced cell elongation and inhibited bacterial cell proliferation without having any detectable effects on either DNA replication or nucleoid segregation. The results indicate that SB-RA-2001 perturbed Z-ring formation in bacteria by promoting the assembly and stability of FtsZ protofilaments. The study suggests that taxane derivatives have the potential to be developed as FtsZ-targeted antibacterial agents.
■ EXPERIMENTAL PROCEDURES
Materials. PIPES, GTP, PMSF, DAPI, lysozyme, Cy3-conjugated goat anti-rabbit secondary antibody, and propidium iodide were procured from Sigma-Aldrich (St. Louis, MO). IPTG was obtained from Calbiochem. Bio-Gel P4 and P6 resin was procured from Bio-Rad. Nickel-NTA was obtained from Qiagen. The rabbit polyclonal FtsZ antibody was obtained from Bangalore Genei. SB-RA-2001 was prepared by the previously reported method at the Ojima laboratory. 21 The BacLight bacterial membrane potential kit was procured from Invitrogen. The Factor Xa cleavage capture kit was obtained from Novagen, EMD chemicals (San Diego, CA).
Preparation of the SB-RA-2001 Stock Solution. SB-RA-2001 was soluble in DMSO. A stock solution of 50 mM was prepared in 100% DMSO and subsequently diluted in aqueous buffer. No precipitate of SB-RA-2001 was visible up to 200 μM in PIPES buffer (pH 6.8).
Purification of Bacillus subtilis FtsZ. B. subtilis FtsZ was purified from Escherichia coli BL21(DE3) pLysS cells transformed with the pET16b vector. 18 Briefly, cells were grown in LB medium containing 12.5 μg/mL chloramphenicol and 100 μg/mL ampicillin and induced at the late log phase (OD 600 = 0.8; 1 mM IPTG) for 6 h. The induced cells were harvested and lysed in ice-cold lysis buffer [50 mM NaH 2 PO 4 (pH 8.0) and 300 mM NaCl] containing 0.1% β-ME, 2 mM PMSF, and 1 mg/mL lysozyme. The protein was purified using nickel-NTA agarose using elution buffer containing 25 mM PIPES (pH 6.8), 300 mM NaCl, and 250 mM imidazole. Purified protein was then desalted using the Biogel P6 resin pre-equilibrated with 25 mM PIPES and 50 mM KCl (pH 6.8). The concentration of purified FtsZ was determined by the Bradford method 23 using BSA as a standard. The concentration of the protein was finally adjusted using a correction factor of 1.2 for the FtsZ/BSA ratio. 24 FtsZ aliquots were stored at −80°C. Prior to each experiment, FtsZ was centrifuged to remove aggregates.
Light Scattering Assay. Goat brain tubulin (10 μM) in 25 mM PIPES buffer (pH 6.8) and 5 mM MgCl 2 was incubated without and with paclitaxel (3 μM) and SB-RA-2001 (10 and 20 μM) at 4°C for 10 min. The polymerization was initiated by adding 1 mM GTP to the reaction mixture, and the assembly of tubulin was monitored at 400 nm using a fluorescence spectrometer (FP-6500, JASCO, Tokyo, Japan) connected to a temperature-controlled bath at 37°C.
The effect of SB-RA-2001 on the assembly kinetics of FtsZ in vitro was determined by 90°light scattering at 500 nm. 25, 26 Briefly, FtsZ (3 μM) was incubated without or with different concentrations (20, 40 , and 60 μM) of SB-RA-2001 in 25 mM PIPES (pH 6.8) containing 50 mM KCl and 5 mM MgCl 2 at 4°C for 10 min. Then, 1 mM GTP was added to the reaction mixtures, and the kinetics of the assembly of FtsZ was monitored at 37°C for 600 s. The light scattering traces of different concentrations of SB-RA-2001 in the absence of FtsZ were also recorded ( Figure S1 of the Supporting Information). At higher concentrations, SB-RA-2001 showed some light scattering; however, the light scattering intensity was much higher in the presence of FtsZ than in its absence. The light scattering traces of SB-RA-2001 alone were subtracted from their respective data set with the protein. After assembly for 10 min, the reaction kinetics reached an apparent equilibrium, and the scattering intensity after assembly for 10 min was used to calculate the extent of assembly. Additionally, the initial rate of the increase in the light scattering intensity of the assembly of FtsZ in the absence and presence of SB-RA-2001 was determined from a linear plot of the light scattering intensity of FtsZ assembly for the first 100 s.
Dilution-Induced Disassembly Assay. FtsZ (5 μM) in 25 mM PIPES buffer (pH 6.8) containing 50 mM KCl, 5 mM MgCl 2 , and 1 mM GTP was polymerized at 37°C for 5 min. The preformed polymers were diluted five times in warm buffer [25 mM PIPES buffer (pH 6.8) containing 50 mM KCl, 5 mM MgCl 2 , and 1 mM GTP] in the absence and presence of different concentrations (20, 40 , and 60 μM) of SB-RA-2001 and incubated at 37°C for 10 min. The polymers were collected through centrifugation (88760g) for 30 min at 30°C, and the pellets were dissolved in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS−PAGE) loading dye [0.25% bromophenol blue, 0.5 M DTT, 50% glycerol, and 10% SDS in 0.25 M Tris-HCl (pH 6.8)]. Samples were resolved via 12% SDS−PAGE, and the intensity of the bands was analyzed with ImageJ Pro Plus.
Sedimentation Assay. FtsZ (3 μM) was incubated without or with different concentrations (20, 40 , and 60 μM) of SB-RA-2001 in 25 mM PIPES buffer (pH 6.8) containing 50 mM KCl and 5 mM MgCl 2 at 4°C for 10 min. Polymerization was conducted in the presence of 1 mM GTP at 37°C for 10 min. The polymers were collected by high-speed centrifugation (88760g) for 30 min at 30°C. The pellets were dissolved in SDS−PAGE loading dye [0.25% bromophenol blue, 0.5 M DTT, 50% glycerol, and 10% SDS in 0.25 M Tris-HCl (pH 6.8)]. Samples were resolved via 12% SDS−PAGE, and band intensity was analyzed with ImageJ Pro Plus.
Characterization of Binding of SB-RA-2001 to FtsZ and Tubulin. Direct binding of SB-RA-2001 to FtsZ and tubulin was assessed using the increase in the fluorescence intensity of SB-RA-2001 upon binding to the proteins. SB-RA-2001 (2 μM) in 25 mM PIPES (pH 6.8) was incubated with either 5 μM FtsZ or 5 μM tubulin at 25°C for 10 min. The fluorescence spectra were recorded in the range of 340−520 nm using 320 nm as an excitation wavelength using a fluorescence spectrometer (FP-6500, JASCO). The fluorescence spectra of the corresponding blanks were recorded and subtracted from the respective data sets. FtsZ and tubulin did not show significant fluorescence in the wavelength range of 340−520 nm. Further, to determine the effect of different concentrations of FtsZ on the fluorescence intensity of SB-RA-2001, SB-RA-2001 (1 μM) was incubated without and with (1, 2, 3, 4, and 5 μM) FtsZ in 25 mM PIPES (pH 6.8) at room temperature for 15 min. The reaction mixtures were excited at 320 nm, and the emission spectra were recorded in the range of 340−520 nm in a fluorescence spectrometer (FP-6500, JASCO).
The change in SB-RA-2001 fluorescence upon binding to FtsZ was used to determine the dissociation constant (K d ) of the SB-RA-2001−FtsZ interaction. FtsZ (2 μM) in 25 mM PIPES (pH 6.8) was incubated in the absence and presence of different concentrations of SB-RA-2001 (2−60 μM) for 15 min at 25°C. After incubation for 15 min, fluorescence spectra were recorded in the range of 340−520 nm using 320 nm as an excitation wavelength. All fluorescence spectra were recorded using a cuvette with a path length of 0.3 cm. The spectra of Because SB-RA-2001 has an absorbance at 320 nm, the spectra were further corrected for the inner filter effect using the equation Electron Microscopy Analysis. FtsZ (3 μM) was incubated in PIPES buffer [25 mM PIPES (pH 6.8), 50 mM KCl, and 5 mM MgCl 2 ] without and with different concentrations (20 and 60 μM) of SB-RA-2001 at 4°C for 10 min. Then, 1 mM GTP was added to each of the reaction mixtures, and polymerization was conducted at 37°C for 10 min. The protein polymers were applied to Formvar carboncoated copper grids (300 mesh) for 30 s and blotted dry. The sample-containing grids were then negatively stained with 1% uranyl acetate for 30 s, dried, and observed under a JEM 2100 ultra HRTEM instrument at 200 kV.
FITC Labeling of FtsZ. FtsZ contains several lysine residues, 27 and one or more of these lysine residues can be covalently modified with FITC. 28 Briefly, FtsZ (20 μM) was incubated with FITC (80 μM) in 25 mM PIPES (pH 6.8) for 4 h on ice. Then, the reaction was quenched with 5 mM TrisHCl. The unbound FITC was removed in two steps: by being passed through a size exclusion column (P4 resin) and then by dialysis against 25 mM PIPES (pH 6. suspensions (10 μL) were then mounted on glass slides and observed using a fluorescence microscope (Eclipse TE2000-U microscope, Nikon, Tokyo, Japan).
GTPase Assay. The C-terminal histidine tag of FtsZ was removed using Factor Xa cleavage capture kit as described recently. 18 The GTP hydrolysis rate of histidine-tagged BsFtsZ and untagged FtsZ was determined by the standard malachite green/ammonium molybdate assay. 26, 29 Both histidine-tagged FtsZ and untagged FtsZ (6 μM) were polymerized at 37°C in 25 mM PIPES buffer (pH 6.8) containing 50 mM KCl, 5 mM MgCl 2 , and 1 mM GTP, and the moles of inorganic phosphate released at various time intervals (1, 3, 5, 10, and 15 min) were determined as described previously. 26 The GTPase activities of His-tagged FtsZ (1.5 ± 0.6 min −1 ) and untagged FtsZ (1.7 ± 0.5 min −1 ) were found to be similar, indicating that the histidine tag does not influence the GTPase activity of FtsZ.
The effects of SB-RA-2001 on the GTPase activity of FtsZ were determined by the malachite green/ammonium molybdate assay. 26, 29 Briefly, FtsZ (3 μM) was incubated without and with different concentrations (20, 40 , and 60 μM) of SB-RA-2001, and the moles of inorganic phosphate released after assembly for 5 min were determined as described above.
Some of the FtsZ-targeted agents have been reported to form colloidal aggregates under assembly conditions. 19 Triton X-100 is used to solubilize the aggregates of the compounds in enzymatic assays. 19 Therefore, the effect of SB-RA-2001 on the GTPase activity of FtsZ was also determined in the presence of 0.01% (v/v) Triton X-100. 19 Initially, SB-RA-2001 (20, 40, and 60 μM) in 25 mM PIPES (pH 6.8), 50 mM KCl, and 5 mM MgCl 2 was incubated with 0.01% Triton X-100 at 37°C for 30 min. Following the incubation, the reaction sets were subjected to centrifugation at 14000g for 20 min, and the supernatants were collected. Subsequently, FtsZ (3 μM) was added to the supernatant having different concentrations of SB-RA-2001 and incubated for 15 min. The polymerization reaction was then initiated by the addition of 1 mM GTP to the reaction sets, and polymerization continued for 5 min at 37°C. The moles of inorganic phosphate released were determined as described previously. 26 Circular Dichroism (CD) Spectroscopy. FtsZ (5 μM) was incubated in the absence and presence of 10 and 20 μM SB-RA-2001 in 25 mM phosphate buffer (pH 6.5) for 10 min at 25°C
. The far-UV CD spectrum was recorded (200−250 nm) using a 0.1 cm path length quartz cuvette in a JASCO J-810 spectropolarimeter. The CD spectra were deconvoluted using CDNN, SSE software from JASCO. Each spectrum was an average of five scans, and the experiment was repeated three times.
Docking Methodology. The molecular docking tool AutoDock4.2 30 was used to identify the putative binding site of SB-RA-2001 on the B. subtilis FtsZ monomer. The threedimensional coordinates of SB-RA-2001 were prepared using the PRODRG server. 31 The X-ray structures of BsFtsZ [Protein Data Bank (PDB) entry 2RHL, A chain] 32 and SaFtsZ (PDB entry 4DXD) 33 were used as models for docking analysis. In SaFtsZ, PC190723 was also present in addition to FtsZ and GDP. PC190723 was extracted prior to the docking simulation. The entire surface of FtsZ was covered in a grid box with dimensions of 170 Å × 170 Å × 170 Å with a grid spacing of 0.375 Å. SB-RA-2001 and PC190723 were used as flexible molecules, and FtsZ was considered as a rigid molecule for the docking analysis. The Lamarckian genetic algorithm was used for docking with default parameters. The docking of SB-RA-2001 and PC190723 to FtsZ was performed by conducting 50 independent jobs, each including 100 runs and yielding 5000 conformations. The clustering of these conformations was performed at a root-mean-square deviation (rmsd) of 6 Å. The clusters having more than 100 conformations were further selected on the basis of binding energy. Finally, the best cluster with minimal energy was chosen for further analysis. The interaction of SB-RA-2001 with FtsZ was analyzed using PyMol. 34 In addition, the structure of BsFtsZ (PDB entry 2RHL), in which docked SB-RA-2001 is present (consisting of docked SB-RA-2001 and GDP), was superimposed on that of β-tubulin. The β-tubulin with GDP and paclitaxel was extracted from tubulin of Bos taurus (PDB entry 1JFF). 35 Effect of SB-RA-2001 on Bacterial Cell Proliferation. B. subtilis 168 cells were grown overnight in LB broth at 37°C and then inoculated into fresh LB tubes at an initial OD 600 of 0.1. The cells were grown in the absence and presence of different concentrations of SB-RA-2001 for 4 h at 37°C. The inhibition of cell proliferation was monitored by measuring OD 600 , and the percent inhibition of cell proliferation was calculated using the formula 10 LB and Middlebrook 7H9 broth media were inoculated with microbial cultures of B. subtilis 168 and M. smegmatis cells, respectively, grown overnight and incubated (4 and 16 h) at 37°C. The cells were fixed at 25°C using 2.8% formaldehyde and 0.04% glutaraldehyde, and then, the cells were pelleted, washed, and resuspended in PBS (pH 7.4). The cell morphology was observed by a differential interference contrast microscope (Eclipse TE2000-U microscope, Nikon) at a 60× magnification. The cell length was measured using Image-Pro Plus (Media Cybernetics, Silver Spring, MD).
Effect of SB-RA-2001 on Z-Ring Formation and Nucleoid Segregation. Immunofluorescence microscopy was performed to visualize the effect of SB-RA-2001 on Zring formation and nucleoid segregation. 9 For visualization of the Z-ring, LB tubes were inoculated with B. subtilis 168 cells GFP-tagged Spo0J in B. subtilis 168 strain HM160 cells (a gift from L. Hamoen, Newcastle University, Newcastle upon Tyne, U.K.) was grown (Casein Hydrolysate Broth containing 2 mg/L kanamycin) at 37°C in the presence of 0.1% DMSO (vehicle) and 20 μM SB-RA-2001 for 4 h. B. subtilis Spo0J cells were harvested and fixed similarly as mentioned above. Nucleoid staining was achieved with 20 μg/mL DAPI. Images were captured using a confocal laser scanning microscope (Olympus, IX 81 with FV-500) at a 60× magnification. Merged images of individual cells were obtained by superimposing GFP-tagged Spo0J and DAPI-stained nucleoids.
FACS Analysis. Fresh LB tubes were inoculated with a culture of B. subtilis 168 cells grown overnight in the absence and presence of 20 μM SB-RA-2001 at 37°C for 4 h. The cells were collected and fixed using a fixing solution (2.8% formaldehyde and 0.04% glutaraldehyde). Untreated and treated cells were permeabilized by subsequent treatments with PBS containing 0.1% Triton X-100 and PBS in the presence of lysozyme and EDTA, respectively. The permeabilized cells were then incubated with 50 μg/mL propidium iodide for 1 h at 25°C in dark. Flow cytometry was performed using FACS Aria (Beckton Dickinson). Analysis of the data was performed using FCS express 4 (research edition, trial version). Effect of SB-RA-2001 on the Membrane Potential of B. subtilis 168 Cells. Inhibition of bacterial cell proliferation can be caused by a perturbed membrane potential in cells. 37 The effect of SB-RA-2001 on the membrane potential of B. subtilis 168 cells was determined using a fluorescent probe, 3,3′-diethyloxacarbocyanine iodide (DiOC 2 ). DiOC 2 exhibits green fluorescence in the monomeric state, and an increase in membrane potential is known to induce self-association of the dye that accompanies the red shift in the spectrum. 38, 39 Therefore, the membrane potential of B. subtilis 168 cells in the absence and presence of SB-RA-2001 was determined using the change in DiOC 2 fluorescence. 38 Briefly, a culture of B. subtilis 168 cells grown overnight was inoculated into fresh LB tubes and grown at 37°C for 2 h. Cells (1 × 10 5 ) were resuspended in filtered PBS and further incubated without or with a positive control (0.2 μM), carbonyl cyanide 3-chlorophenylhydrazone (CCCP), or SB-RA-2001 (20 and 30 μM) at 25°C for 30 min. Then, 12 μM DiOC 2 was added to each of the reaction sets, and the mixtures were further incubated for 30 min in the dark. The reaction mixtures were excited at 470 nm, and the fluorescence emission spectra (500−550 nm) were monitored. Spectra of the respective blanks were also recorded.
Mammalian Cell Proliferation Assay. Human cervical carcinoma (HeLa) cells were cultured in MEM medium (Figure 3) . SB-RA-2001 was found to suppress the GTPase activity of FtsZ in a concentration-dependent fashion. Further, to confirm that the inhibition of the GTPase activity of FtsZ observed in the presence of SB-RA-2001 was not due to the self-aggregation of the compound, the GTPase assay was also performed in the presence of 0.01% Triton X-100. 19 The inhibition of the GTPase activity of FtsZ by SB-RA-2001 was found to be similar in the absence and presence of 0.01% Triton X-100 (Figure 3 Putative Binding Site of SB-RA-2001 on FtsZ. Initially, docking of PC190723 was performed on SaFtsZ as a control ( Figure S4 of the Supporting Information). The PC190723 topology was extracted from SaFtsZ (PDB entry 4DXD). 33 The docked conformation of PC190723 was compared with the Xray crystallographically determined structure ( Figure S4 of the Supporting Information and Table 1) , and the root-meansquare deviation (rmsd) between docked PC190723 and crystallized PC190723 was estimated to be 0.951 Å, indicating appropriate docking. 30, 43 Further, docking of SB-RA-2001 and PC190723 on BsFtsZ (PDB entry 2RHL) 32 was performed using a similar methodology.
SB-RA-2001 was docked into the BsFtsZ structure to determine the putative binding site and the residues of BsFtsZ involved in the interaction with SB-RA-2001 ( Figure 5 ). An analysis of the docking results indicated that SB-RA-2001 bound to FtsZ in a cleft region between helix H7 and the Cterminal domain. Further, the residues of BsFtsZ within 4 Å of the SB-RA-2001 moiety were identified (Table 2) , and the bold residues in Table 2 are the BsFtsZ residues common to both PC190723 and SB-RA-2001 identified through docking analysis. SB-RA-2001 was forming hydrophobic and hydrogen bonding interactions with BsFtsZ. The five residues of BsFtsZ (E305, R191, Q192, N188, and N33) were observed to be hydrogen bonded to SB-RA-2001 ( Figure 5 ). Because the mechanism of action of SB-RA-2001 was similar to that of PC190723, 13 we docked SB-RA-2001 on BsFtsZ in combination with PC190723 ( Figure 5 ). Interestingly, both SB-RA-2001 and PC190723 were found to bind to analogous binding pockets in BsFtsZ and also to share some interacting residues (Table 2) H37Rv (drug-sensitive) and IMCJ946 K2 (multi-drugresistant) with MICs of 5 and 1.25 μM, respectively. 
PC190723
(docked)
Arg29, Glu32, Asn33, Asn188, Arg191, Gln192, Gln195, Gly196, Asp199, Ile230, Asn263, Thr265, Asn299, Asn301, Leu302, Lys303, Glu305, Val307, Thr309
a The common residues of docked PC190723 and SB-RA-2001 are shown in bold. Because the Z-ring acts as a scaffold for the recruitment of several cell division proteins, its perturbation is expected to affect their positioning at the midcell.
1 Therefore, the effect of SB-RA-2001 on the cellular localization of DivIVA, a protein that remains at both the poles and is recruited to the Z-ring at the onset of septal constriction, was examined. 44 In the untreated cells, GFP-tagged DivIVA showed the expected pattern of localization, i.e., at the midcell and poles, whereas DivIVA was mostly located at the two poles and was no longer recruited to the prospective cell division site in the SB-RA-2001-treated cells ( Figure 8A) . Moreover, the presence of punctate spots of DivIVA and FtsZ through the cell length indicated the presence of incomplete Z-ring formation in the presence of SB-RA-2001. The perturbed localization of DivIVA supported the finding that Z-ring formation was hampered in the presence of 20 μM SB-RA-2001. Further, the merged images of GFP-tagged DivIVA and Cy3-stained FtsZ also confirmed that FtsZ assembly at the midcell was affected.
Septum formation can be inhibited either by direct interference with the cell division machinery or by impaired nucleoid segregation. 45 The quantification of DNA in SB-RA-2001-treated cells was achieved using flow cytometric analysis. The median fluorescence intensity of propidium iodide-stained SB-RA-2001-treated cells was found to increase by several-fold It should be noted that SB-RA-2001 is different from paclitaxel because of the presence of the (E)-3-(naphtha-2-yl)acryloyl (2-NpCHCHCO) group in place of the Nbenzoylisoserine moiety at the C13 position of the paclitaxel molecule. The results indicated that the substitution at C13 contributed to the substantially different effects of SB-RA-2001 on FtsZ and tubulin. This structure−activity relationship analysis was further supported by an analysis in which the structures of tubulin and BsFtsZ were superimposed on each other to obtain a clear view of a probable paclitaxel binding site on FtsZ. In this respect, the crystal structures of tubulin (PDB entry 1JFF) and BsFtsZ (PDB entry 2RHL) were superimposed on each other and structurally aligned using PyMol to determine the residues of BsFtsZ that were in the proximity of the paclitaxel binding site in tubulin. The BsFtsZ residues close to the paclitaxel-like site projected to be bound by docked PC190723 and SB-RA-2001 have been highlighted (Table. 3). Interestingly, it was observed that there was no similarity between the identified residues of tubulin and FtsZ (Table 3) , which were located within 4 Å of the paclitaxel binding site in tubulin. 13 The A recent study has suggested that some of the FtsZ-targeted compounds such as totarol, Zantrin Z1, and 4′-hydroxydichamanetin might inhibit the GTPase activity of FtsZ through the mechanism of selfaggregation of the compound. 19 The mechanism of action of SB-RA-2001 on FtsZ resembled that of microtubule-stabilizing agent paclitaxel. In vitro, paclitaxel promotes tubulin assembly; however, in cells, it triggers cell death by stabilizing microtubules, which prevents the formation and functioning of the mitotic spindle. 48 In a similar manner, SB-RA-2001 also promoted the assembly and bundling of FtsZ protofilaments in vitro but perturbed the formation of Z-rings in cells. Similar effects were also shown by other FtsZ-stabilizing agents such as OTBA and PC190723; these agents promoted the bundling of FtsZ in vitro but prevented Z-ring formation in cells. 13, 17 In silico analysis of binding of SB-RA-2001 to FtsZ indicated that the taxane derivative binds to BsFtsZ in the interdomain cleft region, adjacent to helix H7. Helix H7 is an integral part of the BsFtsZ structure and bridges the N-and C-terminal domains of FtsZ. Helix H7 in turn is anchored to the N-and C-terminal regions through H-bonded interactions between residues Arg29 and Asn188 and residues Gly196 and Asn263, respectively. 49 Interestingly, all four of these residues were involved in the binding interactions of SB-RA-2001 with BsFtsZ. It is therefore predicted that the absence of the H-bonded interactions might have ruptured the interactions between N-and C-terminal domains. A similar mechanism of action was reported for the FtsZ-polymerizing agent, PC190723, in which the compound promoted FtsZ assembly and bound to a region similar to that of SB-RA-2001. Docking analysis suggested SB-RA-2001 and PC190723 may bind to analogous binding pockets on FtsZ ( Figure 5 and Table 2 ), indicating a common mechanism of 
a The residues of BsFtsZ close to paclitaxel-like site projected to be bound by docked PC190723 and SB-RA-2001 are shown in bold.
action for the two inhibitors. Moreover, PC190723 was reported to bind to FtsZ at a site that was comparable to the paclitaxel binding site in tubulin, and like the tubulin polymerization enhancing activity of paclitaxel, PC190723 also enhances the assembly of FtsZ. An analysis of the superimposition studies indicated that like PC190723, SB-RA-2001 also binds to FtsZ at a site that is similar to the paclitaxel binding domain in tubulin ( Figure S8 of the Supporting Information). Therefore, SB-RA-2001 may stabilize FtsZ polymers through a mechanism that is similar to the mechanism of action of paclitaxel on microtubules.
The Because the Z-ring is capable of generating force for bacterial cell division, its perturbation can block bacterial cell division, leading to elongated B. subtilis 168 cells. 50 We also found that upon SB-RA-2001 treatment, DivIVA was no longer recruited to the future cell division sites and was concentrated at the cell poles of B. subtilis cells. This finding suggested that DivIVA did not associate with the perturbed FtsZ ring wherein significant membrane constriction is absent. The structural role of DivIVA in the cell division of Gram-positive bacteria by recruiting other proteins to cell division sites has also been reported. 51, 52 DivIVA was also reported to have essential roles in chromosome segregation and cell wall synthesis. 53 Moreover, the division site selection mechanism of the MinCD system was found to be regulated by DivIVA through an interacting protein MinJ. 54 An analysis of the structural domains of DivIVA revealed that it consists of a lipid binding N-terminal domain and a C-terminal domain. 55 While transmembrane protein MinJ was found to interact with the N-terminal domain of DivIVA, the C-terminal domain was involved in the binding interactions of RacA, a protein essential for chromosome segregation under sporulation conditions. 56 The perturbed localization of DivIVA in SB-RA-2001-treated B. subtilis cells indicated the formation of defective FtsZ rings. Spo0J is an initiation marker for DNA segregation in B. subtilis cells at the onset of DNA duplication. 57 The 
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